Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEZNZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,474
Award facts
- Contract value 100% obligated
- $48,473.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $48,473.90 and is scheduled for completion by August 13, 2025. The contract includes no set-aside designation, reflecting open competition among qualified vendors. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV infection, indicating this award supports pharmaceutical supply needs within federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to fulfill federal medical procurement requirements and serves as a critical vendor for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEZNZ?
SPE2DB25FEZNZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FEZNZ worth?
The government has obligated $48,474 on SPE2DB25FEZNZ.
Is contract SPE2DB25FEZNZ an order under another contract?
Yes. SPE2DB25FEZNZ is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZNZ competed?
The extent of competition for SPE2DB25FEZNZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award